Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Diagnostics (Basel, Switzerland)|July 27, 2022
VEXAS Syndrome: A Novelty in MDS LandscapeMarie Templé, Olivier KosmiderDiagnostics (Basel, Switzerland)|July 27, 2022
The Mesenchymal Niche in Myelodysplastic SyndromesChloé Friedrich, Olivier KosmiderBulletin Du Cancer|July 15, 2023
[MDS & CMML: Diagnostic and classification]Orianne Wagner-Ballon, Olivier KosmiderBest Practice & Research. Clinical Haematology|February 11, 2014
Somatic mutations and epigenetic abnormalities in myelodysplastic syndromesRaphael Itzykson, Olivier Kosmider, Pierre FenauxExpert Review of Hematology|April 29, 2023
VEXAS: is it time to reshape the nosology of clonal hematopoiesis?Pierre Sujobert, Laetitia Largeaud, Yvan Jamilloux, et al.Blood|November 30, 2006
Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiationPauline Rimmelé, Olivier Kosmider, Patrick Mayeux, et al.Plos One|June 4, 2009
Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinaseOlivier Kosmider, Dorothée Buet, Isabelle Gallais, et al.Current Opinion in Hematology|January 11, 2017
Dyserythropoiesis of myelodysplastic syndromesCarine Lefèvre, Sabrina Bondu, Salomé Le Goff, et al.Cancer Cell|December 13, 2005
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in miceOlivier Kosmider, Nicole Denis, Catherine Lacout, et al.The Lancet. Haematology|February 1, 2024
Vacuoles in bone marrow progenitors: VEXAS syndrome and beyondValentin Lacombe, Jérome Hadjadj, Sophie Georgin-Lavialle, et al.Pageof 12